ClinicalTrials.gg
Drug

Gemfibrozil clinical trials

Also written Lopid and PLX-200.

studies test it
14
open now
1
in phase 3
2
first study started
1991

How each study uses Gemfibrozil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Gemfibrozil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 1981 · LOPID · NDA 018422 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Gemfibrozil
12

Brand

Lopid
2

Development codes

PLX-200
2

Studies by the year they started

13 studies that test it; most in 2014 (2); 1 more planned to start later

Studies that test Gemfibrozil, by start year
YearStudies
19911
20041
20051
20071
20101
20121
20142
20151
20161
20181
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
5
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 6

Polaryx Therapeutics, Inc. (2) · Actelion (1) · Gregory Jicha, 323-5550 (1) · University of Texas Southwestern Medical Center (1) · Eli Lilly and Company (1) · GlaxoSmithKline (1) · Centre for Addiction and Mental Health (1) · VA Office of Research and Development (1)

Often tested with

Tested in the same studies.

Selexipag (1) · Rifampin (1) · Evacetrapib (1) · GSK1278863 (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Gemfibrozil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Given beside what is tested · 15 — Gemfibrozil is usual care or a partner of the new treatment

Codes

What other systems call Gemfibrozil · ClinicalTrials.gg INT008450

  • MeSH (NLM) D015248GemfibrozilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Q8X02027X3GEMFIBROZILConfirmed FDA, NLM, Wikidata
  • RxNorm 4719Confirmed FDA, Wikidata
  • Wikidata Q384295gemfibrozilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29071GemfibrozilOne source FDA
  • DrugBank DB01241One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.